Not all antistatic valved holding chambers have equivalent performance: An example why each valved holding chamber (VHC)-inhaler combination should be considered unique

J. Malpass, M. Nagel, V. Avvakoumova, R. Ali, H. Schneider, J. Mitchell (London, Canada)

Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Session: The best of pharmacology treatments of airway diseases: new devices and drugs
Session type: Thematic Poster Session
Number: 2154
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Malpass, M. Nagel, V. Avvakoumova, R. Ali, H. Schneider, J. Mitchell (London, Canada). Not all antistatic valved holding chambers have equivalent performance: An example why each valved holding chamber (VHC)-inhaler combination should be considered unique. Eur Respir J 2012; 40: Suppl. 56, 2154

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Performance of a valved holding chamber with tracheostomy adapter: comparison with conventional valved holding chamber
Source: Eur Respir J 2001; 18: Suppl. 33, 134s
Year: 2001

Comparing five antistatic valved holding chambers: how antistatic are they really?
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC)
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

In vitro performance of a new non-electrostatic, transparent valved holding chamber (VHC) for the poorly coordinated patient
Source: Eur Respir J 2004; 24: Suppl. 48, 380s
Year: 2004

A small volume valved holding chamber (VHC) manufactured from charge dissipative materials has comparable in vitro performance with a large volume non-conducting plastic spacer for both bronchodilator and anti-inflammatory formulations
Source: Eur Respir J 2005; 26: Suppl. 49, 340s
Year: 2005

Patient centered development of a new valved holding chamber (VHC) designed specifically for on-the-go use
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Impact of inspiratory delay and valved holding chamber (VHC) material on drug delivery
Source: Eur Respir J 2001; 18: Suppl. 33, 494s
Year: 2001

New anti-static youth valved holding chamber (VHC) can be used out-of-package and deliver β2-agonist medication effectively
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Priming of a non-conducting valved holding chamber (VHC) is formulation dependent and may result in inconsistent medication delivery
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007


Breath-by-breath delivered dose comparison from three anti-static valved holding chambers with facemasks under simulated pediatric breathing conditions
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011

Are there differences in throat deposition using variable valved holding chambers (VHC)?
Source: Eur Respir J 2006; 28: Suppl. 50, 713s
Year: 2006

Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

In vitro comparison of the effect of inhalation delay on the variability of the delivered dose from valved holding chambers
Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy
Year: 2012


In-vitro performance of two valved holding chambers (VHCs)/Spacers for paediatric use tested with facemasks attached is unaffected by routine use and cleaning
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Novel non-electrostatic valved holding chamber (VHC) has comparable in vitro performance for delivery of beta-2 agonist as similar-sized, pre-washed but non-conducting VHC
Source: Eur Respir J 2006; 28: Suppl. 50, 211s
Year: 2006

Delivery of medication via a novel non-electrostatic valved holding chamber (VHC) for infant use depends on the number of inhalations
Source: Eur Respir J 2006; 28: Suppl. 50, 713s
Year: 2006

In vitro performance of a small non-electrostatic valved holding chamber made from metal with three different brands of pressurized metered dose inhalers
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

Valved holding chamber drug delivery is dependent on breathing pattern and device design
Source: ERJ Open Res, 5 (1) 00158-2018; 10.1183/23120541.00158-2018
Year: 2019



Substantial in vitro equivalence exists for non-conducting (NC) and anti-static (AS) valved holding chambers (VHCs) provided pre-conditioning of the non-conducting VHC is undertaken
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Is pretreatment of a valved holding chamber (VHC) by priming with medication as effective as washing in ionic detergent?
Source: Eur Respir J 2004; 24: Suppl. 48, 308s
Year: 2004